104 related articles for article (PubMed ID: 11565955)
1. Phase 1, randomized, double-blind trial of 7-allyl-8-oxoguanosine (loxoribine) in advanced cancer.
Agarwala SS; Kirkwood JM; Bryant J
Cytokines Cell Mol Ther; 2000 Dec; 6(4):171-6. PubMed ID: 11565955
[TBL] [Abstract][Full Text] [Related]
2. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
[TBL] [Abstract][Full Text] [Related]
3. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.
Pope BL; Chourmouzis E; Victorino L; MacIntyre JP; Capetola RJ; Lau CY
J Immunol; 1993 Sep; 151(6):3007-17. PubMed ID: 8376766
[TBL] [Abstract][Full Text] [Related]
4. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
[TBL] [Abstract][Full Text] [Related]
5. In vivo enhancement of murine natural killer cell activity by 7-allyl-8-oxoguanosine (loxoribine).
Pope BL; Chourmouzis E; Sigindere J; Capetola RJ; Lau CY
Int J Immunopharmacol; 1992 Nov; 14(8):1375-82. PubMed ID: 1464469
[TBL] [Abstract][Full Text] [Related]
6. 7-Allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine.
Pope BL; Sigindere J; Chourmouzis E; MacIntyre P; Goodman MG
Cancer Immunol Immunother; 1994 Feb; 38(2):83-91. PubMed ID: 8306370
[TBL] [Abstract][Full Text] [Related]
7. The immunostimulatory compound 7-allyl-8-oxoguanosine (loxoribine) induces a distinct subset of murine cytokines.
Pope BL; MacIntyre JP; Kimball E; Lee S; Zhou L; Taylor GR; Goodman MG
Cell Immunol; 1995 May; 162(2):333-9. PubMed ID: 7743561
[TBL] [Abstract][Full Text] [Related]
8. A new approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine.
Goodman MG
Pharm Biotechnol; 1995; 6():581-609. PubMed ID: 7551237
[TBL] [Abstract][Full Text] [Related]
9. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole.
Keenan JA; Williams-Boyce PK; Massey PJ; Chen TT; Caudle MR; Bukovsky A
Fertil Steril; 1999 Jul; 72(1):135-41. PubMed ID: 10428162
[TBL] [Abstract][Full Text] [Related]
10. Topology of the loxoribine binding site. Studies with inactive loxoribine analogues.
Goodman MG; Goodman JH
J Immunol; 1994 Nov; 153(9):4081-7. PubMed ID: 7930614
[TBL] [Abstract][Full Text] [Related]
11. New perspectives on the approach to chronic lymphocytic leukemia.
Goodman MG; Spinosa JC; Saven A; Piro LD; Wormsley S
Leuk Lymphoma; 1996 Jun; 22(1-2):1-10. PubMed ID: 8724523
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of immunostimulatory activity by dual substitution of C8-substituted guanine ribonucleosides: correlation with increased cytokine secretion.
Pope BL; Chourmouzis E; Lee S; Goodman MG
J Immunother Emphasis Tumor Immunol; 1995 Feb; 17(2):98-108. PubMed ID: 7647961
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic combination of loxoribine with fludarabine and mafosfamide on freshly isolated B-chronic lymphocytic leukemia cells.
Pellacani A; Tosi P; Zinzani PL; Ottaviani E; Albertini P; Magagnoli M; Tura S
Leuk Lymphoma; 1999 Mar; 33(1-2):147-53. PubMed ID: 10194132
[TBL] [Abstract][Full Text] [Related]
14. Loxoribine, a selective Toll-like receptor 7 agonist, induces maturation of human monocyte-derived dendritic cells and stimulates their Th-1- and Th-17-polarizing capability.
Dzopalic T; Dragicevic A; Vasilijic S; Vucevic D; Majstorovic I; Bozic B; Balint B; Colic M
Int Immunopharmacol; 2010 Nov; 10(11):1428-33. PubMed ID: 20817120
[TBL] [Abstract][Full Text] [Related]
15. Small-molecule immunostimulants. Synthesis and activity of 7,8-disubstituted guanosines and structurally related compounds.
Reitz AB; Goodman MG; Pope BL; Argentieri DC; Bell SC; Burr LE; Chourmouzis E; Come J; Goodman JH; Klaubert DH
J Med Chem; 1994 Oct; 37(21):3561-78. PubMed ID: 7932584
[TBL] [Abstract][Full Text] [Related]
16. Selective modulation of elements of the immune system by low molecular weight nucleosides.
Goodman MG; Reitz AB; Chen R; Bobardt MD; Goodman JH; Pope BL
J Pharmacol Exp Ther; 1995 Sep; 274(3):1552-7. PubMed ID: 7562533
[TBL] [Abstract][Full Text] [Related]
17. Loxoribine affects fludarabine activity on freshly isolated B-chronic lymphocytic leukemia cells.
Tosi P; Zinzani PL; Pellacani A; Ottaviani E; Magagnoli M; Tura S
Leuk Lymphoma; 1997 Jul; 26(3-4):343-8. PubMed ID: 9322897
[TBL] [Abstract][Full Text] [Related]
18. Phase I evaluation of combination therapy with interleukin 2 and gamma-interferon.
Weiner LM; Padavic-Shaller K; Kitson J; Watts P; Krigel RL; Litwin S
Cancer Res; 1991 Aug; 51(15):3910-8. PubMed ID: 1906779
[TBL] [Abstract][Full Text] [Related]
19. Thiazolo[4,5-d]pyrimidine nucleosides. The synthesis of certain 3-beta-D-ribofuranosylthiazolo[4,5-d]pyrimidines as potential immunotherapeutic agents.
Nagahara K; Anderson JD; Kini GD; Dalley NK; Larson SB; Smee DF; Jin A; Sharma BS; Jolley WB; Robins RK
J Med Chem; 1990 Jan; 33(1):407-15. PubMed ID: 2153211
[TBL] [Abstract][Full Text] [Related]
20. Successful immunotherapy of murine melanoma metastases with 7-thia-8-oxoguanosine.
Sharma BS; Balazs L; Jin A; Jolley WB; Robins RK
Clin Exp Metastasis; 1991; 9(5):429-39. PubMed ID: 1914279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
